Although TGF-β acts as tumour suppressor at the early stage of cancer, it becomes an oncogenic factor at advanced stages by triggering cell invasion and stimulating cancer cell intravasation to proximal tissues, and extravasation into distal tissues [59]. This evidence concerns the gene TGFB1 and neoplasm.